Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials

Background: Fremanezumab (TEV-48125) is a fully-humanized immunoglobulin G isotype 2a selective monoclonal antibody that potently binds to calcitonin gene-related peptide (CGRP). It is one of the novel therapeutic drugs for the prevention of migraine, which is one of the most common neurological dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Gao, Bixi, Sun, Nan, Yang, Yanbo, Sun, Yue, Chen, Mingjia, Chen, Zhouqing, Wang, Zhong
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7248404/
https://ncbi.nlm.nih.gov/pubmed/32508742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00435
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados